Litcius/Paper detail

Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients

Luca Mastorino, Franco Castelli, Elena Stroppiana, Anna Verrone, Michela Ortoncelli, Sara Susca, Sara Boskovic, S.G. Passerini, Nicole Macagno, Caterina Cariti, M. Licciardello, C. Solaroli, G. Pertusi, M.G. Aragone, G. Baggini, C. Addese, C. Leporati, R. Peila, M.T. Giura, Gianluca Rossotto, Paolo Pella, L. Mocci, Giulia Merlo, R. Tiberio, F. Graziola, Pietro Quaglino, Paolo Dapavo, Simone Ribero

2022Journal of the European Academy of Dermatology and Venereology22 citationsDOI

Topics & Concepts

DermatologySection (typography)MedicinePsoriasisUniversity hospitalMedical schoolLibrary scienceFamily medicineMedical educationComputer scienceOperating systemPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAutoimmune Bullous Skin Diseases
Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients | Litcius